| Disease Subtype(s) |
HCT Disease Inserts Required |
Cellular Therapy Disease Inserts Required |
B-Lymphoblastic Leukemia/Lymphoma
- B-lymphoblastic leukemia/lymphoma, NOS (191)
- B-lymphoblastic leukemia/lymphoma with BCR::ABL1 fusion (192)
- B-lymphoblastic leukemia/lymphoma with KMT2A rearrangement (193)
- B-lymphoblastic leukemia/lymphoma with TCF3::PBX1 fusion (194)
- B-lymphoblastic leukemia/lymphoma with ETV6::RUNX1 fusion (195)
- B-lymphoblastic leukemia/lymphoma with IGH::IL3 fusion (81)
- B-lymphoblastic leukemia/lymphoma with high hyperdiploidy (82)
- B-lymphoblastic leukemia/lymphoma with hypodiploidy (83)
- B-lymphoblastic leukemia/lymphoma with BCR::ABL1 -like features (94)
- B-lymphoblastic leukemia/lymphoma, with iAMP21 (95)
- B-lymphoblastic leukemia/lymphoma with ETV6::RUNX1 -like features (1111)
- B-lymphoblastic leukemia/lymphoma with TCF3::HLF fusion (1112)
B-Lymphoblastic Leukemia/Lymphoma with Other Defined Genetic Abnormalities
- B-lymphoblastic leukemia/lymphoma with DUX4 rearrangement (1113)
- B-lymphoblastic leukemia/lymphoma with IG::MYC fusion (1114)
- B-lymphoblastic leukemia/lymphoma with MEF2D rearrangement (1115)
- B-lymphoblastic leukemia/lymphoma with ZNF384 rearrangement (1116)
- B-lymphoblastic leukemia/lymphoma with NUTM1 rearrangement (1117)
- B-lymphoblastic leukemia/lymphoma with PAX5alt abnormalities (1118)
- B-lymphoblastic leukemia/lymphoma with PAX5 p.P80R abnormalities (1119)
T-Cell Lymphoblastic Leukemia/Lymphoma
- T-cell lymphoblastic leukemia/lymphoma (196)
- Early T-precursor lymphoblastic leukemia/lymphoma (96)
- Early T-precursor lymphoblastic leukemia/lymphoma, with BCL11B rearrangement (1120)
NK Cell Lymphoblastic Leukemia/Lymphoma
- Natural killer (NK)-cell lymphoblastic leukemia/lymphoma (97)
|
Form 2011 & 2111 |
Form 2011 & 2111 |
Last modified:
May 29, 2024
